H.R.1392 - To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.111th Congress (2009-2010)
|Sponsor:||Rep. Green, Gene [D-TX-29] (Introduced 03/09/2009)|
|Committees:||House - Energy and Commerce; Ways and Means|
|Latest Action:||03/10/2009 Referred to the Subcommittee on Health.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: H.R.1392 — 111th Congress (2009-2010)All Bill Information (Except Text)
Introduced in House (03/09/2009)
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.